Global Renal Denervation Market Size, Share, Forecast Report, 2020-2027

The global renal denervation market is expected to rise at a solid CAGR of 40.4% over the 2018-2023 forecast period, with the market’s value rising from USD 200 million in 2017 to USD 2,850 million in 2023.

The Global Renal Denervation Market is majorly driven by the rising prevalence of hypertension across the world. According to the CDC, the prevalence of hypertension was close to 26% among adults aged 20 years or more in 2000. There has been a 5.2% increase in the prevalence of hypertension over the next ten years, making it a prime concern for the healthcare sector in countries across the globe. Developed countries have been proactive in taking measures to counteract and reduce the prevalence of hypertension among their population, leading to growing support for the renal denervation market.

Renal denervation is a minimally invasive procedure aimed at treating resistant hypertension. The process uses RF or ultrasound ablation upon nerves in the renal artery to reduce sympathetic activity in the kidney and reduce blood pressure.
Segmentation:

The global renal denervation market is segmented on the basis of product, technology, and end use.

By product, the renal denervation market is segmented into Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and others. Symplicity holds the largest market share in the renal denervation market at present and is likely to remain a leading contributor over the forecast period. However, Paradise is likely to be the fastest growing product segment in the renal denervation market over the forecast period.

On the basis of technology, the global renal denervation market is divided into radiofrequency, ultrasound, micro-infusion, and others. Radiofrequency is likely to be the fastest growing segment over the forecast period, eclipsing ultrasound, the largest market segment at present, in terms of growth rate.

By end user, the renal denervation market is segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are the largest segment in the global renal denervation market, while ambulatory surgical centers are expected to exhibit the fastest growth over the forecast period.

By region, the global renal denervation market is segmented into North America, Europe, Asia Pacific (APAC), and Rest of the world.

Global Renal Denervation Market by Product

• Symplicity
• Vessix (V2)
• EnligHTN
• Paradise
• Iberis
• Others

Global Renal Denervation Market by Technology

• Radiofrequency
• Ultrasound
• Micro-infusion
• Others

Global Renal Denervation Market by End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others